STIM
Neuronetics, Inc.
$3.00
-2.91%
2026-08-21
About Neuronetics, Inc.
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Key Fundamentals
Forward P/E
-9.71
EPS (TTM)
$-0.43
ROE
-116.1%
Revenue Growth (YoY)
9.1%
Profit Margin
-19.6%
Debt/Equity
399.83
Price/Book
14.10
Beta
1.12
Market Cap
$229.6M
Avg Volume (10D)
5.0M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$3.44
60D Low
$1.17
Avg Volume
2.3M
Latest Close
$3.00
Get breakout alerts for STIM
Sign up for Breakout Scanner to receive daily notifications when STIM triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Neuronetics, Inc. (STIM) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors STIM daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. STIM operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.